The objective of the iPlacenta project is to develop state-of-the-art models to mimic the placenta in vitro. This Huffington...
Today, the exposition ‘Frankenstein: towards a new human’ has been opened officially by the Dutch writer...
MIMETAS, the market leader in Organ-on-a-chip products, announced that the National Cancer Institute recently awarded them a...
In this paper, we investigate the feasibility of adapting OrganoPlate® technology for therapy selection for breast cancer....
Karlijn Wilschut, Senior Scientist at Mimetas and Oksana Sirenko, Research Scientist at Molecular Devices wrote this...
Jos Joore and Paul Vulto presents MIMETAS' organ-on-a-chip platform: the OrganoPlate® in the July (2017) edition of...
On July 25, 2017 an interview with Paul Vulto about Mimetas was published at i-Micronews.
During this two-day hands-on training hosted by MIMETAS you will learn everything about the current applications of organ-on...
MIMETAS collaborator Lawrence Vernetti explains in Nature News the importance of regulatory approval for replacing animal...
This review evaluates Organ-on-a-Chip efforts published over the last two years in light of end-user adoption aspects.
In this webinar, MIMETAS and Molecular Devices present OrganoPlates® as a novel microfluidic culture platform enabling long-...
Nature Medicine covers MIMETAS and OrganoPlate®. "Channeling chip power: Tissue chips are being put to the test by industry...
In a move to serve customers with ready-to-use solutions for organ-on-a-chip model development and analysis, MIMETAS and...
In collaboration with Biogen, Abbvie and Janssen, academic partners and SMEs, MIMETAS will develop neurovascular organs-on-...
On December 9, 2016 our paper on 3D neuronal cultures in OrganoPlates was published in Nature Scientific Reports.
The NIH has awarded MIMETAS and the University of Pittsburgh a prestigious SBIR grant to develop a Liver-on-a-Chip platform...
MIMETAS is now a member of the HollandBIO community
MIMETAS, Galapagos, (Euronext & NASDAQ: GLPG), and University of Sheffield, have embarked on a collaboration to develop...
In the 1.5mn euro HepaPlate™ project, MIMETAS will develop an organ-on-a-chip hepatotoxicity-screening platform for...
MIMETAS welcomes André Hoekema and Bart Bergstein as members of the board. Dr. Hoekema is Senior Vice President Corporate...
Jos Joore presents MIMETAS' vision on personalized medicine based on phenotypic therapy selection at the TEDxBINNENHOF event...
The Horizon 2020 project CoSTREAM aims to improve our understanding of the co-...
In this review we address the application of state-of-the-art microfluidic culturing techniques, with a focus on culturing...
Mimetas has received 1.6 million USD funding for development of an organ-on-a-chip model for neurotoxicity. The aim of the...
On Thursday December the 3rd, MIMETAS has won the annual contest for the GameChanger of the Year award.
MIMETAS takes part in a new Parkinson's project to identify drugs that slow down neurodegeneration in PD patients with overt...
At the SME Assembly on November 20 in Luxembourg Jos Joore has convinced the jury with a pitch about Mimetas' OrganoPlates...
Mimetas is covered in GEN Sept 15, 2015 in an article entitled "Feng Shui Basics for 3D Cell Culture"
The review provides a comprehensive overview of how such factors, called morphogens, influence blood-brain barrier integrity...
MIMETAS receives EFRO grant for feasibility study
Paul Vulto in article in Nature of July 16, 2015 by Sara Reardon entitled "Organs-on-chips go mainstream", also quoting...
In their article "On-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro", Mi Jang et...
Building High-Throughput Organs-on-Chips, An interview by Chris Vickrey and Asuka Ishikawa for U.S. Pharmaceutical Industry...
MIMETAS and the IRAS receive funding from GlaxoSmithKline, BASF, Sanofi, Abbvie and NC3Rs for a proof-of-concept study to...
MIMETAS B.V. announces that it has raised 5.2 million dollar to fund its expansion as a global leader in organ-on-a-chip...
MIMETAS has won the MipTec 2014 innovation award for the OrganoPlate®.
MIMETAS, in a consortium with Radboudumc and FHNW, has received 1.6 million USD funding for development of a kidney-on-a-...
On September 3, 2014 Mimetas received the ELRIG Drug Discovery 2014 Technology Prize for the OrganoPlate®.